Literature DB >> 28190678

A unique natural selective kappa-opioid receptor agonist, salvinorin A, and its roles in human therapeutics.

André Cruz1, Sara Domingos1, Eugenia Gallardo2, Ana Martinho3.   

Abstract

Until the mid-60s, only the Mazatecs, an indigenous group from Oaxaca, Mexico, used Salvia Divinorum (S. divinorum) due to its hallucinogen properties. Later it was found that the hallucinogen effects of this plant were caused by the presence of a neoclerodane diterpene Salvinorin A (salvinorin A), which is a highly selective agonist of kappa-opioid receptor (KOR) that cause more intense hallucinations than the common hallucinogens as lysergic acid, mushrooms, ecstasy and others. In fact, smoking of only 200-500 μg of S. divinorum leaves is enough to produce these effects thus making it the most potent natural occurring hallucinogen known. Due to its legal status in various countries, this compound has gained a worldwide popularity as a drug of abuse with an easy access through smartshops and internet. Furthermore, salvinorin A gathered an increased interest in the scientific community thanks to its unique structure and properties, and various studies demonstrated that salvinorin A has antinociceptive, antidepressant, in some circumstances pro-depressant and anti-addictive effects that have yielded potential new avenues for research underlying salvinorin A and its semi-synthetic analogs as therapeutic agents.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Hallucinogen; Kappa-opioid receptor; Lamiaceae family; Salvia divinorum; Salvinorin A; Therapeutics

Mesh:

Substances:

Year:  2017        PMID: 28190678     DOI: 10.1016/j.phytochem.2017.02.001

Source DB:  PubMed          Journal:  Phytochemistry        ISSN: 0031-9422            Impact factor:   4.072


  7 in total

Review 1.  A review of salvinorin analogs and their kappa-opioid receptor activity.

Authors:  Jeremy J Roach; Ryan A Shenvi
Journal:  Bioorg Med Chem Lett       Date:  2018-03-12       Impact factor: 2.823

2.  Addressing Structural Flexibility at the A-Ring on Salvinorin A: Discovery of a Potent Kappa-Opioid Agonist with Enhanced Metabolic Stability.

Authors:  Alexander M Sherwood; Rachel Saylor Crowley; Kelly F Paton; Andrew Biggerstaff; Benjamin Neuenswander; Victor W Day; Bronwyn M Kivell; Thomas E Prisinzano
Journal:  J Med Chem       Date:  2017-04-19       Impact factor: 7.446

3.  Antinociceptive effect and mechanism of supercritical carbon dioxide extract of Aloysia gratissima leaves in mice.

Authors:  Maryelen A Souza; Jaqueline Scapinello; João G G Guzatti; Mikaela Scatolin; Rafael Martello; Monica S Z Schindler; Jean F F Calisto; Bianca Alves; Letícia V Morgan; J Vladimir Oliveira; Jacir Dal Magro; Liz G Müller
Journal:  Biomed J       Date:  2020-07-02       Impact factor: 7.892

Review 4.  An Update on the Implications of New Psychoactive Substances in Public Health.

Authors:  Ana Y Simão; Mónica Antunes; Emanuel Cabral; Patrik Oliveira; Luana M Rosendo; Ana Teresa Brinca; Estefânia Alves; Hernâni Marques; Tiago Rosado; Luís A Passarinha; Maristela Andraus; Mário Barroso; Eugenia Gallardo
Journal:  Int J Environ Res Public Health       Date:  2022-04-17       Impact factor: 4.614

5.  Therapeutic Potential of Salvinorin A and Its Analogues in Various Neurological Disorders.

Authors:  Joseph Cichon; Renyu Liu; Hoang V Le
Journal:  Transl Perioper Pain Med       Date:  2022-06-29

6.  Natural Products: Therapeutic Properties and Beyond II.

Authors:  Ana Paula Duarte; Ângelo Luís; Eugenia Gallardo
Journal:  Molecules       Date:  2022-09-20       Impact factor: 4.927

7.  Salvinorin A Does Not Affect Seizure Threshold in Mice.

Authors:  Katarzyna Socała; Urszula Doboszewska; Piotr Wlaź
Journal:  Molecules       Date:  2020-03-07       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.